These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 139203)

  • 41. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.
    Roth JA; Golub SH; Grimm EA; Eilber FR; Morton DL
    Surgery; 1976 Jan; 79(1):46-51. PubMed ID: 128842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node, spleen and peripheral blood lymphocytes as stimulators of alloreactivity.
    Puc M; Humar I; Bulić-Jakus F
    Coll Antropol; 2011 Jun; 35(2):369-76. PubMed ID: 21755705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Sep; 119(3):1122-8. PubMed ID: 70470
    [No Abstract]   [Full Text] [Related]  

  • 45. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes.
    Vose BM; Vánky F; Argov S; Klein E
    Eur J Immunol; 1977 Nov; 7(11):353-7. PubMed ID: 304003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions.
    Berlinger NT; Good RA
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of water-soluble adjuvants on in vitro lymphocyte immunization.
    Sharma B; Koashi O; Mickey MR; Terasaki P
    Cancer Res; 1975 Mar; 35(3):666-9. PubMed ID: 123169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and phenotypic analysis of lymphocytes in head and neck cancer.
    Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.
    Flannery GR; Chalmers PJ; Rolland JM; Nairn RC
    Br J Cancer; 1973 Aug; 28(2):118-22. PubMed ID: 4542343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies on host immunity in cervical cancer--alterations in nonspecific and specific immunity of tumor growth (author's transl)].
    Yamada Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Nov; 32(11):1820-8. PubMed ID: 7240835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro.
    Waldman SR; Roth JA; Kern DH; Pilch YH
    J Lab Clin Med; 1975 Dec; 86(6):950-61. PubMed ID: 127818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neck node immunoreactivity in head and neck carcinoma.
    Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
    Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Autologous lymphocytotoxicity against squamous cell carcinoma in head and neck. I. In vitro culture of squamous cell carcinoma in head and neck (author's transl)].
    Ikawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Dec; 84(12):1570-8. PubMed ID: 7341742
    [No Abstract]   [Full Text] [Related]  

  • 54. [A study of T gamma cells in the regional lymph nodes of patients with uterine cervical cancer].
    Hiramatsu K; Ueda G; Inoue M; Tanaka Y; Inoue Y; Saito J; Nishino T; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):947-52. PubMed ID: 6223965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T-lymphocytes phenotype and functions in patients with head and neck cancer.
    Pierri I; Cordone G; Rogna S; Piccardo C; Barabino A; Indiveri F
    Laryngoscope; 1985 May; 95(5):577-81. PubMed ID: 3157845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy.
    Ambus U; Mavlight GM; Gutterman JU; McBride CM; Hersh EM
    Int J Cancer; 1974 Sep; 14(3):291-300. PubMed ID: 4142467
    [No Abstract]   [Full Text] [Related]  

  • 58. Target cell destruction in vitro by concanavalin A-stimulated lymphoid cells.
    Schwartz HJ; Wilson F
    Am J Pathol; 1971 Aug; 64(2):295-304. PubMed ID: 5142268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonspecific immunity and head and neck cancer: blastogenesis reviewed and revisited.
    Eskinazi DP; Helman J; Ershow AG; Perna JJ; Mihail R
    Oral Surg Oral Med Oral Pathol; 1985 Dec; 60(6):642-7. PubMed ID: 3865136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Covalent linking of proteins and cytokines to suture: enhancing the immune response of head and neck cancer patients.
    Shibuya TY; Kim S; Nguyen K; Parikh P; Wadhwa A; Brockardt C; Do J
    Laryngoscope; 2003 Nov; 113(11):1870-84. PubMed ID: 14603040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.